Clinical trial
Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With…
NCT00046904 · Mayo Clinic, Other · Completed
Key facts
| NCT number | NCT00046904 |
|---|---|
| Title | Etanercept in Treating Cancer-Related Cachexia and Anorexia in Patients With Advanced Cancer |
| Official title | Phase III Placebo-Controlled, Randomized, Double-Blind Comparison Of Etanercept (Enbrel) Versus Placebo For The Treatment Of Cancer-Associated Weight Loss And Anorexia |
| Lead sponsor | Mayo Clinic, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anorexia, Cachexia, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological |
| Interventions | etanercept |
| Start date | May 1, 2003 |
| Primary completion | Sep 1, 2007 |
| First posted | Jan 27, 2003 |
| Last update posted | May 5, 2011 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: